Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions Proactive Investors 6:11 5 months ago 651 Скачать Далее
Cramer: This biotech stock could be worth over $100 billion on an FDA approval CNBC Television 5:19 4 years ago 403 200 Скачать Далее
Roche's weight loss adjacent drugs will boost its competitiveness, CEO says CNBC International TV 3:57 15 hours ago 45 Скачать Далее
How Next-Gen Biosensors and AI Will Change Pandemic Detection and Health Monitoring Fortune Magazine 14:40 1 day ago 890 Скачать Далее
Biopharmaceutical company says it expects to reach profitability in 2025 CNBC International TV 3:05 1 year ago 125 Скачать Далее
GW Pharma CEO talks Epidiolex sales amid the pandemic CNBC Television 2:03 3 years ago 3 431 Скачать Далее
Expect to see a lot of market volatility for the next several months: Hightower's Stephanie Link CNBC Television 2:44 12 hours ago 6 449 Скачать Далее
Fmr. FDA Commissioner Dr. Scott Gottlieb on FDA approval of CRISPR treatment, CVS' new drug model CNBC Television 6:01 7 months ago 7 683 Скачать Далее
Patients describe Casgevy gene-editing treatment as a cure, says Vertex CEO Reshma Kewalramani CNBC Television 3:25 7 months ago 8 262 Скачать Далее
Biohaven CEO discusses Pfizer's purchase of the company CNBC Television 1:50 2 years ago 1 906 Скачать Далее
11 - Refining Selected Chemicals to be Better Drugs - Interview with Dr. David Fry CancerQuest-EmoryUniversity 1:02 11 years ago 28 Скачать Далее
It’s unusual for countries to compete for approving drugs, the FDA isn’t far behind: Hassan CNBC Television 2:54 3 years ago 991 Скачать Далее
